Latest News
This semiconductor supplier, critical to chip and display manufacturing, reported a notable insider sale amid a year of strong share gains.
Via The Motley Fool · April 4, 2026
Should you invest in this healthcare giant now?
Via The Motley Fool · April 4, 2026
Berkshire Hathaway created a model that others, including Brookfield Corporation, are trying to follow.
Via The Motley Fool · April 4, 2026
Via Talk Markets · April 4, 2026

Trump proposes $152 million plan to reopen Alcatraz, drawing political criticism and logistical concerns.
Via Benzinga · April 4, 2026
Laffont's taking some risk off the table and shifting to a stalwart semiconductor stock.
Via The Motley Fool · April 4, 2026
Oil prices skyrocketed last month.
Via The Motley Fool · April 4, 2026
Both Nvidia and TSMC should be solid stocks to own, but one looks like the better long-term buy.
Via The Motley Fool · April 4, 2026
It has consistently shown that it's equipped to do so.
Via The Motley Fool · April 4, 2026
The right investing strategy can help protect against volatility.
Via The Motley Fool · April 4, 2026

Tesla is chasing its biggest opportunity yet.
Via The Motley Fool · April 4, 2026
After a massive sell-off, this CEO thinks his company's stock is a bargain.
Via The Motley Fool · April 4, 2026
A few key moves could help your money last.
Via The Motley Fool · April 4, 2026
A few extra working years can be a game changer for your monthly benefits.
Via The Motley Fool · April 4, 2026
Nvidia's growth trajectory could go parabolic.
Via The Motley Fool · April 4, 2026
Realty Income has increased its dividend for 32 straight years.
Via The Motley Fool · April 4, 2026

Via Benzinga · April 4, 2026
CarMax recently appointed a new CEO and is facing pressure from an activist investor.
Via The Motley Fool · April 4, 2026
Most of this stock's gain, however, has only taken shape since the company launched its defining product.
Via The Motley Fool · April 4, 2026
The chipmaker is altering its manufacturing strategy -- and investors like the implications.
Via The Motley Fool · April 4, 2026
It took a while, but Copilot may finally be on the right track.
Via The Motley Fool · April 4, 2026
Via Benzinga · April 4, 2026
Both of these companies are proven trailblazers.
Via The Motley Fool · April 4, 2026
The U.S. Food & Drug Administration just approved Eli Lilly's GLP-1 pill orforglipron.
Via The Motley Fool · April 4, 2026